Dr. Carl Gay, MD
Claim this profileM D Anderson Cancer Center
Studies Lung Cancer
Studies Small Cell Lung Cancer
3 reported clinical trials
6 drugs studied
Area of expertise
1Lung Cancer
Stage III
2Small Cell Lung Cancer
Stage III
Stage IV
SLFN11 positive
Affiliated Hospitals
More about Carl Gay, MD
Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Carl Gay, MD has experience with
- Dostarlimab
- Niraparib
- Atezolizumab
- Talazoparib
- CAB-AXL-ADC
- PD-1 Inhibitor
Breakdown of trials Carl Gay, MD has run
Lung Cancer
Small Cell Lung Cancer
Small Cell Carcinoma
Neuroendocrine Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Carl Gay, MD specialize in?
Carl Gay, MD focuses on Lung Cancer and Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are undergoing treatment.
Is Carl Gay, MD currently recruiting for clinical trials?
No, Carl Gay, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Carl Gay, MD has studied deeply?
Yes, Carl Gay, MD has studied treatments such as Dostarlimab, Niraparib, Atezolizumab.
What is the best way to schedule an appointment with Carl Gay, MD?
Apply for one of the trials that Carl Gay, MD is conducting.
What is the office address of Carl Gay, MD?
The office of Carl Gay, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.